Leptin attenuates cardiac apoptosis after chronic ischaemic injury

Cardiovascular Research

Volumn 83, Issue 2, 2009, Pages 313-324

  Mcgaffin, Kenneth R ^a   Zou, Baobo ^a   Mctiernan, Charles F ^a   O'donnell, Christopher P ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Apoptosis; bcl 2; Heart failure; Leptin; Survivin

Indexed keywords

CASPASE 3; LEPTIN; PROTEIN BCL 2; STAT3 PROTEIN; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATORY CELL; ISOLATED HEART; LEFT CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHAM PROCEDURE; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CASPASE 3; CHRONIC DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; INFLAMMATION; LEPTIN; LIGATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIDINES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TYRPHOSTINS;

EID: 67650257499     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp071     Document Type: Article

References (30)

1. Khoynezhad A, Ziba J, Tortolani AJ. A synopsis of research in cardiac apoptosis and its application to congestive heart failure. Tex Heart Inst J 2007;34:352-359.
2. Garg S, Naruka J, Chandrashekhar Y. Apoptosis and heart failure: clinical relevance and therapeutic target. J Mot Celt Cardiol 2005;38:73-79.
3. Abbate A, Biondi-Zoccai GG, Baldi A. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol 2002;193:145-153.
4. Kang P, Izumo S. Apoptosis in heart failure: a critical review of the literature. Circ Res 2000;86:1107-1113.
5. Abbate A, DeFalco M, Morales C, Gelpi RJ, Prisco M, DeLuca A et al. Electron microscopy characterization of cardiomyocyte apoptosis in ischemic heart disease. Int J Cardiol 2006;114:118-120.
6. Trivedi P, Yang R, Barouch LA. Decreased p110a catalytic activity accompanies increased myocyte apoptosis and cardiac hypertrophy in leptin deficient ob/ob mice. Cell Cycle 2008;7:560-565.
7. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003;111:1497-1504.
8. Wolf B, Green DR. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 1999;274:20049-20052.
9. van Empel V, Bertrand ATA, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ. Myocyte apoptosis in heart failure. Cardiovasc Res 2005;67:21 -29.
10. Azamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2001;2:67-71.
11. HengartnerM. The biochemistry of apoptosis. Nature 2000;407:770-776.
12. Crow M, Mani K, Nam KJ, Kitsis RN. The mitochondial death pathway and cardiac myocyte apoptosis. Circ Res 2004;95:957-970.
13. Verhagen AM, Coulson EJ, Vaux DL. Inhibitor of apoptosis proteins and their relatives: lAPs and other BIRPs. Genome Biol 2001;2:3001- 3010.
14. Levkau B, Shafers M, Wohlschlaeger J, von Wnuck Lipinski K, Keul P, Hermann S et al. Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation 2008;117:1583-1593.
15. Weisleder N, Taffet GE, Capetanaki Y. Bcl-2 overexpression corrects mito- chondrial defects and ameliorates inherited desmin null cardiomyopathy. Proc Natl Acad Sci USA 2004;101:769-774.
16. Bhattacharya S, Ray RM, Johnson LR. STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem J 2005;392:335-344.
17. Jiang H, Yu J, GuoH, SongH, ChenS. Upregulationof survivinbyleptin-STAT3 signaling in MCF7 cells. Biochem Biophys Res Commun 2008;368:1-5.
18. McGaffin KR, Sun CK, Rager JJ, Romano LC, Zou B, Mathier MA et al. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc Res 2008;77:54-63.
19. Equchi M, Liu Y, Shin EJ, Sweeney G. Leptin protects H9c2 rat cardiomyo- cytes from H2O2-induced apoptosis. FEBS J 2008;275:3136-3144.
20. Barouch L, Gao D, Lei C, Miller KL, Xu W, Phan AC et al. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res 2006;98:119-124.
21. Kong L, Abou-Ghazal MK, Wei J, Chakraborty A, Sun W, Qiao W et al. A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory Tcells. Clin Cancer Res 2008;14:5759-5768.
22. Kanda T, Takahashi T, Kudo S, Takeda T, Tsugawa H, Takekoshi N. Leptin deficiency enhances myocardial necrosis and lethality in a murine model of viral myocarditis. Life Sci 2004;75:1435-1447.
23. Van den Bergh A, Vanderper A, Vangheluwe P, Desjardins F, Nevelsteen I, Verreth W et al. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc Res 2008;77:371-379.
24. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999;276:R136-R142.
25. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, Grunfeld C et al. Leptin-deficient (ob/ob) mice are protected from Tcellmediated hepatotoxicity: role of tumor necrosis factor-a and IL-18. Proc Natl Acad Sci USA 2000;97:2367-2372.
26. Dube MG, Torto R, Kalra SP. Increased leptin expression selectively in the hypothalamus suppresses inflammatory markers CRP and IL-6 in leptin- deficient diabetic obese mice. Peptides 2008;29:593-608.
27. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH. Overexpressin of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 2001;280:H2313-H2320.
28. Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B et al. Pharmacological preconditioning with tumor necrosis factor-a activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (akt and extracellular signal- regulated kinase). Circulation 2005;112:3911-3918.
29. Mattioli B, Straface E, Quaranta MG, Giordani L, Viora M. Leptin promotes differentiation and survival of human dendritic cells and licenses them forTh1 priming. J Immunol 2005;174:6820-6828.
30. Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 2002;99:6252-6256.